Entry Detail



General Information

Database ID:exR0000026
RNA Name:ABCA1
RNA Type:mRNA
Chromosome:chr9
Starnd:-
Coordinate:
Start Site(bp):104781006End Site(bp):104928155
External Links:ENSG00000165029



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
COX5B
chr2
97646062
97648383
+
EIF3L
chr22
37848868
37889407
+
EWSR1
chr22
29268009
29300525
+
FEN1
chr11
61792911
61797238
+
GANAB
chr11
62624826
62646726
-
GAPDH
chr12
6534512
6538374
+
HADH
chr4
107989714
108035175
+
IGF2
chr11
2129112
2141238
-
IGF2BP3
chr7
23310209
23470491
-
KDM3B
chr5
138352685
138437028
+
LSMEM1
chr7
112480853
112491062
+
LUC7L3
chr17
50719565
50756219
+
MPI
chr15
74890005
74902219
+
NISCH
chr3
52455118
52493068
+
PIANP
chr12
6693792
6700800
-
PPRC1
chr10
102132994
102150333
+
RPL13A
chr19
49487554
49492308
+
RPL14
chr3
40457292
40468587
+
RPL19
chr17
39200283
39204732
+
RPS23
chr5
82273320
82278396
-
SEC11A
chr15
84669538
84716460
-
SHROOM3
chr4
76435229
76783253
+
SND1
chr7
127652194
128092609
+
UBE2R2
chr9
33817160
33920399
+
ZNF217
chr20
53567065
53609907
-
ZNF568
chr19
36916329
36998700
+
ZNF696
chr8
143289676
143299952
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-1294
chr5
154347153
154347174
+
circRNA targets:NA
lncRNA targets:NA
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.